AOS vs LEXXW · P/E 19, rev $1.00B vs rev $705.9K
Smith AO Corporation (AOS) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the AOS and LEXXW stock pages for the full models.
Not investment advice.